Samsung Group Set To Enter Biosimilars Market With $1.9 Billion Investment
This article was originally published in The Pink Sheet Daily
Executive Summary
Samsung Group says biosimilar and device moves are part of larger plan to invest $20.6 billion in five new business sectors by 2020.
You may also be interested in...
Korea's Samsung Electronics On Manhunt For Biosimilar Talent As Local Companies Keep Wary Eye On Competition
SEOUL - South Korea's leading biosimilar companies such as LG Life Sciences, Celltrion and others are increasingly wary of Samsung Electronics' ongoing talent search for research and development experts as the company prepares to make its debut in the blooming biosimilar business
Korea Moves To Help Samsung Electronics Create Consortium in Biosimilars
SEOUL - As the South Korean government accelerates its drive to get local producers of biosimilars globally competitive, the Ministry of Knowledge Economy is setting the stage for Samsung Electronics to become a giant in the emerging biosimlars market
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.